These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pathology of occlusive cerebrovascular diseases]. Tanaka K; Yamashita M No To Shinkei; 1983 Jan; 35(1):7-16. PubMed ID: 6651975 [No Abstract] [Full Text] [Related]
5. [Autoimmune aspects of the humoral picture in arteriosclerotic disease]. Fiorentini P; Evangelisti GB; Marabini GF G Clin Med; 1971 Sep; 52(9):666-80. PubMed ID: 5149802 [No Abstract] [Full Text] [Related]
6. [Clinical significance of changes in the immunological reactivity in cerebral circulation disorders]. Semenova EP; Gustov AV; Kuznetsova LL; Mironova EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(9):1313-7. PubMed ID: 4765019 [No Abstract] [Full Text] [Related]
7. [Quantitative characteristics of the state of the T- and B-systems of immunity in the peripheral blood of patients with cerebrovascular disorders]. Molchanov VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1299-306. PubMed ID: 6605633 [TBL] [Abstract][Full Text] [Related]
8. [On cerebrovascular fits in old age]. Barolin GS; Reisner H Wien Klin Wochenschr; 1968 Jan; 80(1):1-5 passim. PubMed ID: 5650707 [No Abstract] [Full Text] [Related]
9. [Cerebrovascular circulation disorders form the neurological viewpoint]. Gänshirt H Med Welt; 1970 Jan; 4():119-24. PubMed ID: 4910407 [No Abstract] [Full Text] [Related]
10. [Diseases associated with ischemic cerebrovascular disorders]. Autio L Duodecim; 1973; 89(5):390-9. PubMed ID: 4727004 [No Abstract] [Full Text] [Related]
13. [Clinical aspects and treatment of cerebral circulation disorders]. Scharfetter C Ther Ggw; 1968 Apr; 107(4):431-46. PubMed ID: 5672318 [No Abstract] [Full Text] [Related]
14. [Cerebrovascular diseases in Russia: results and perspectives]. Suslina ZA Ter Arkh; 2008; 80(10):5-8. PubMed ID: 19105404 [No Abstract] [Full Text] [Related]
15. Psychiatric aspects of cerebrovascular disease in the aged. Butler RN Res Publ Assoc Res Nerv Ment Dis; 1966; 41():255-66. PubMed ID: 5957651 [No Abstract] [Full Text] [Related]
16. Autoimmunity in Down's syndrome: another possible mechanism of Moyamoya disease. Leno C; Mateo I; Cid C; Berciano J; Sedano C Stroke; 1998 Apr; 29(4):868-9. PubMed ID: 9550527 [No Abstract] [Full Text] [Related]
17. [Studies of the administration of ustimon and instenon in cerebrovascular diseases]. Pichler E; Strauss A Wien Klin Wochenschr; 1968 Jan; 80(4):61-4 passim. PubMed ID: 5667714 [No Abstract] [Full Text] [Related]
18. [Clinical and neuroradiological aspects in the infantile form of Moyamoya disease]. Dal-Bianco P; Reisner T; Friedrich MH; Spiel W Padiatr Padol; 1983; 18(1):29-37. PubMed ID: 6835680 [No Abstract] [Full Text] [Related]
19. [Significance of the ophthalmodynamogram (ODG) in cerebral circulary disorders: a preliminary report]. Finke J; Buchthal A Z Kardiol; 1973 Nov; 62(11):977-89. PubMed ID: 4776811 [No Abstract] [Full Text] [Related]
20. Evaluation of patients for surgery. I. Neurological considerations. Kertesz A Int Anesthesiol Clin; 1984; 22(3):31-44. PubMed ID: 6480135 [No Abstract] [Full Text] [Related] [Next] [New Search]